Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T van Oosterom

Showing results (191-200 of 196) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 196 results.
Oncology|January 1, 1992
Multicenter phase II study of spiroplatinB C Tanis, J B Vermorken, W W ten Bokkel Huinink, et al.
European Journal of Cancer (Oxford, England : 1990)|December 7, 2005
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumoursC N Sternberg, P de Mulder, J H Schornagel, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma GroupI Judson, J A Radford, M Harris, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupL Svancárová, J Y Blay, I R Judson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancerR Bruno, D Hille, A Riva, et al.
Investigational New Drugs|May 11, 2002
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studiesJ H M Schellens, B Heinrich, M Lehnert, et al.
Pageof 20

Showing results (191-200 of 196) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 196 results.
Oncology|January 1, 1992
Multicenter phase II study of spiroplatinB C Tanis, J B Vermorken, W W ten Bokkel Huinink, et al.
European Journal of Cancer (Oxford, England : 1990)|December 7, 2005
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumoursC N Sternberg, P de Mulder, J H Schornagel, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma GroupI Judson, J A Radford, M Harris, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupL Svancárová, J Y Blay, I R Judson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancerR Bruno, D Hille, A Riva, et al.
Investigational New Drugs|May 11, 2002
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studiesJ H M Schellens, B Heinrich, M Lehnert, et al.
Pageof 20